Harnessing drug resistance: using ABC transporter proteins to target cancer cells.
about
New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapiesSelect cyclopentenone prostaglandins trigger glutathione efflux and the role of ABCG2 transportReplication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.Casiopeína IIgly-induced oxidative stress and mitochondrial dysfunction in human lung cancer A549 and H157 cellsTargeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.Targeting maladaptive glutathione responses in lung disease.Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: the role of glutathione.2',5'-Dihydroxychalcone-induced glutathione is mediated by oxidative stress and kinase signaling pathways.ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma.CFTR is the primary known apical glutathione transporter involved in cigarette smoke-induced adaptive responses in the lungABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer.Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics.Regulation of p21, MMP-1, and MDR-1 expression in human colon carcinoma HT29 cells by Tian Xian liquid, a chinese medicinal formula, in vitro and in vivo.Thiomaltol-Based Organometallic Complexes with 1-Methylimidazole as Leaving Group: Synthesis, Stability, and Biological Behavior.Comprehensive and Holistic Analysis of HT-29 Colorectal Cancer Cells and Tumor-Bearing Nude Mouse Model: Interactions Among Fractions Derived From the Chinese Medicine Formula Tian Xian Liquid in Effects on Human Colorectal Carcinoma.Biological Entanglement-Like Effect After Communication of Fish Prior to X-Ray Exposure.
P2860
Q28067499-39EFEAB3-D9BB-4291-8F65-0EB0BBB01B8FQ33466591-4EAEED43-E347-4373-B759-7F81A334B446Q33553382-96E5F8DC-CCE3-44BF-8EDA-950091EBE432Q33678876-1263FEE2-3BAA-4D59-A621-5C36ABE5373CQ33763765-B9DE2C70-0C76-4D16-8970-4A1042A114CDQ34574707-BA187F04-D0FC-4FEF-898A-544E8E4F7F3DQ35671428-48D01828-D25A-44B0-B353-B7FB121B3B52Q35671439-D5792818-A66C-46DF-8BEB-461166B4FEFFQ37365043-15BF9CBE-054E-46CB-99B5-A5672454EFE9Q37576905-539F18E6-3292-414E-8A2C-53D0D506E3A5Q37595188-B5937210-8F4E-47A2-A26A-67CF52F650ADQ38207943-F88F1CCD-3EC6-47DD-91F3-9C09C8BE4C4AQ39668549-1A98C0E4-3C9E-44E4-A605-B26B4094A709Q46475362-411170C4-8A52-4790-985A-8A480840E9FFQ49360921-47A88399-AEDB-471D-BF89-E38E624BE8EAQ50301019-B024D452-A22B-4D32-8967-DB2A57BE7BB4
P2860
Harnessing drug resistance: using ABC transporter proteins to target cancer cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Harnessing drug resistance: using ABC transporter proteins to target cancer cells.
@ast
Harnessing drug resistance: using ABC transporter proteins to target cancer cells.
@en
type
label
Harnessing drug resistance: using ABC transporter proteins to target cancer cells.
@ast
Harnessing drug resistance: using ABC transporter proteins to target cancer cells.
@en
prefLabel
Harnessing drug resistance: using ABC transporter proteins to target cancer cells.
@ast
Harnessing drug resistance: using ABC transporter proteins to target cancer cells.
@en
P2093
P2860
P1476
Harnessing drug resistance: using ABC transporter proteins to target cancer cells.
@en
P2093
Brian J Day
Heather M Leitner
Remy Kachadourian
P2860
P304
P356
10.1016/J.BCP.2007.05.014
P407
P577
2007-05-21T00:00:00Z